Additionally, the prognostic value of PLIN5 has been explored in many cancers, including breast cancer (35), pancreatic cancer (24), hepatocellular carcinoma (25), and so on; however, we first investigated the prognostic role of mutated PLIN5 in patients with GC. This evidence concerns the gene PLIN5 and familial pancreatic carcinoma.